Literature DB >> 33234740

Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.

Kaihua Chen1, Ling Li1,2,3, Song Qu1,2,3, Xinbin Pan1, Yongchu Sun1, Fangzhu Wan1, Binbin Yu1, Lei Zhou1, Xiaodong Zhu1,2,3.   

Abstract

OBJECTIVE: This study aimed to explore the effect of silencing hTERT on the CSC-like characteristics and radioresistance of CNE-2R cells.
RESULTS: Silencing hTERT suppressed CNE-2R cell proliferation and increased the cell apoptosis rate and radiosensitivity in vitro. Moreover, it could also inhibit the growth of xenografts and increase the apoptosis index and radiosensitivity in vivo. Further study discovered that after silencing hTERT, telomerase activity in CNE-2R cells was markedly suppressed, along with remarkably down-regulated stem cell-related protein levels both in vitro and in vivo.
CONCLUSION: Silencing hTERT can suppress the CSC-like characteristics of CNE-2R cells to enhance their radiosensitivity, revealing that hTERT may become a potential target for treating radioresistant NPC.
METHODS: An RNAi lentiviral vector specific to the hTERT gene was constructed to infect CNE-2R cells, the hTERT silencing effect was verified through qPCR and Western blot assays, and telomerase activity was detected by PCR-ELISA. Moreover, radiosensitivity in vitro was detected through colony formation assays, CCK-8 assays and flow cytometry. Tumor growth and radioresistance were also evaluated using xenograft models, while the apoptosis index in xenografts was measured through TUNEL assay. Levels of stem cell-related proteins were determined in vitro and in vivo.

Entities:  

Keywords:  RNA interference; cancer stem cells; hTERT; nasopharyngeal carcinoma; radioresistance

Mesh:

Substances:

Year:  2020        PMID: 33234740      PMCID: PMC7803545          DOI: 10.18632/aging.104167

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  59 in total

1.  Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.

Authors:  Katrin Hoffmeyer; Angelo Raggioli; Stefan Rudloff; Roman Anton; Andreas Hierholzer; Ignacio Del Valle; Kerstin Hein; Riana Vogt; Rolf Kemler
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

2.  Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.

Authors:  Xiangrong Sharon Qi; Frank Pajonk; Susan McCloskey; Daniel A Low; Patrick Kupelian; Michael Steinberg; Ke Sheng
Journal:  Radiother Oncol       Date:  2017-09-17       Impact factor: 6.280

3.  Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.

Authors:  Jin Su; Xin-Hua Xu; Qiao Huang; Ming-Qian Lu; Dao-Jun Li; Feng Xue; Fang Yi; Jing-Hua Ren; Yi-Pin Wu
Journal:  Arch Med Res       Date:  2011-01       Impact factor: 2.235

4.  Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks.

Authors:  Ya Guo; Xiao-Dong Zhu; Song Qu; Ling Li; Fang Su; Ye Li; Shi-Ting Huang; Dan-Rong Li
Journal:  Int J Oncol       Date:  2011-08-19       Impact factor: 5.650

5.  Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.

Authors:  Yi-Wei Chen; Kuan-Hsuan Chen; Pin-I Huang; Yu-Chih Chen; Guang-Yu Chiou; Wen-Liang Lo; Ling-Ming Tseng; Han-Sui Hsu; Kuo-Wei Chang; Shih-Hwa Chiou
Journal:  Mol Cancer Ther       Date:  2010-11-09       Impact factor: 6.261

6.  Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Authors:  Xiaochun Zhang; Ritsuko Komaki; Li Wang; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

7.  Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.

Authors:  Simone Wesbuer; Claudia Lanvers-Kaminsky; Ines Duran-Seuberth; Tobias Bölling; Karl-Ludwig Schäfer; Yvonne Braun; Normann Willich; Burkhard Greve
Journal:  Radiat Oncol       Date:  2010-07-19       Impact factor: 3.481

8.  Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.

Authors:  Quan Yuan; Honghao Yu; Jianhua Chen; Xiaoyu Song; Li Sun
Journal:  Exp Cell Res       Date:  2017-11-16       Impact factor: 3.905

9.  Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.

Authors:  Wenbo Wang; Lei Yang; Liu Hu; Fen Li; Li Ren; Haijun Yu; Yu Liu; Ling Xia; Han Lei; Zhengkai Liao; Fuxiang Zhou; Conghua Xie; Yunfeng Zhou
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities.

Authors:  Ji-Hye Jung; Ka-Won Kang; Jihea Kim; Soon-Chul Hong; Yong Park; Byung Soo Kim
Journal:  Stem Cells Dev       Date:  2016-07-01       Impact factor: 3.272

View more
  3 in total

1.  Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro.

Authors:  Chengle Zhuang; Changshui Zhuang; Qun Zhou; Xueting Huang; Yaoting Gui; Yongqing Lai; Shangqi Yang
Journal:  Front Mol Biosci       Date:  2021-03-19

Review 2.  Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies.

Authors:  Mahshid Deldar Abad Paskeh; Shafagh Asadi; Amirhossein Zabolian; Hossein Saleki; Mohammad Amin Khoshbakht; Sina Sabet; Mohamad Javad Naghdi; Mehrdad Hashemi; Kiavash Hushmandi; Milad Ashrafizadeh; Sepideh Mirzaei; Ali Zarrabi; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

3.  Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic.

Authors:  Yuewen Zhang; Lei Wu; Zhao Wang; Jinpeng Wang; Shrabasti Roychoudhury; Bartlomiej Tomasik; Gang Wu; Geng Wang; Xinrui Rao; Rui Zhou
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.